Regenicin OverviewRegenicin EBIT
EBIT (Earnings Before Interest and Taxes) analysis for RGIN.
Quarterly EBIT
$0.00
As of Sep 30, 2023
Annual EBIT (TTM)
-$631.03K
↓ 1.19% YoY
Trailing 12 months ending Sep 30, 2023
Regenicin OverviewEBIT (Earnings Before Interest and Taxes) analysis for RGIN.
As of Sep 30, 2023
Trailing 12 months ending Sep 30, 2023